Endorectal magnetic resonance imaging for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions
Urol Oncol
.
2016 Oct;34(10):477-8.
doi: 10.1016/j.urolonc.2016.06.006.
Epub 2016 Aug 31.
Authors
Felipe Couñago
1
,
Elia Del Cerro
1
,
Ana Aurora Díaz-Gavela
1
,
Francisco José Marcos
1
,
Manuel Recio
2
,
David Sanz-Rosa
3
,
Israel Thuissard
4
,
Karmele Olaciregui
5
,
María Mateo
6
,
Laura Cerezo
7
Affiliations
1
Department of Radiation Oncology, Hospital Universitario Quiron, Madrid, Spain.
2
Department of Radiology, Hospital Universitario Quiron, Madrid, Spain.
3
Clinical Department, School of Biomedical Sciences, Universidad Europea, Madrid, Spain.
4
Pharmacy and Biotechnology Department, School of Biomedical Sciences, Universidad Europea, Madrid, Spain.
5
School of Biomedical Sciences, Universidad Europea, Madrid, Spain.
6
Hospital Universitario Quiron, Madrid, Spain.
7
Departament of Radiation Oncology, Hospital Universitario La Princesa, Madrid, Spain.
PMID:
27590360
DOI:
10.1016/j.urolonc.2016.06.006
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Magnetic Resonance Imaging*
Magnetic Resonance Spectroscopy
Male
Prostatic Neoplasms*